Veracyte® SEC Filings

Filing date	Form	Description	View
Mar 17, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001384101-23-000042.pdf 0001384101-23-000042.xls
Mar 16, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001384101-23-000040.pdf 0001384101-23-000040.xls
Mar 15, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-000030.pdf 0001950047-23-000030.xls
Mar 9, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001384101-23-000035.pdf 0001384101-23-000035.xls
Mar 9, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001384101-23-000037.pdf 0001384101-23-000037.xls
Mar 9, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001384101-23-000038.pdf 0001384101-23-000038.xls
Mar 9, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001384101-23-000036.pdf 0001384101-23-000036.xls
Mar 3, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001384101-23-000027.pdf 0001384101-23-000027.xls
Mar 3, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001384101-23-000029.pdf 0001384101-23-000029.xls
Mar 3, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001384101-23-000030.pdf 0001384101-23-000030.xls

Data provided by Kaleidoscope.

Contact Information

Investors:

investors@veracyte.com
619.393.1545

Media:

Tracy Morris
tracy.morris@veracyte.com
650.380.4413

Disclaimer

The information in our press releases and webcasts should be considered accurate only as of the date of the press release or presentation. We disclaim any obligation to supplement or update the information in these press releases or presentations.